Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary
Abstract Narcolepsy is associated with disrupted nighttime sleep (DNS). Sodium oxybate (SXB; Xyrem®), administered twice nightly, is indicated for the treatment of cataplexy and excessive daytime sleepiness in patients 7 years or older with narcolepsy. Recently, low-sodium oxybate (LXB, Xywav®; for...
Main Authors: | Russell Rosenberg, Rogelio Braceras, Wayne Macfadden, Shawn Candler, Jed Black, Chad Ruoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-09-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-023-00543-z |
Similar Items
-
Individualized Treatment Patterns for Patients with Narcolepsy Treated with Oxybate: A Clinical Practice Perspective
by: Roy A, et al.
Published: (2023-09-01) -
Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate
by: Tomi eSarkanen, et al.
Published: (2014-08-01) -
Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary
by: Thomas Roth, et al.
Published: (2023-11-01) -
Preferences for Attributes of Sodium Oxybate Treatment: A Discrete Choice Experiment in Patients with Narcolepsy
by: Dubow J, et al.
Published: (2022-04-01) -
Treatment paradigms for cataplexy in narcolepsy: past, present, and future
by: Swick TJ
Published: (2015-12-01)